BioSyent Stock

BioSyent Dividend

The Dividend of BioSyent (RX.V) as of Aug 3, 2026 is 0.20 CAD. In the previous year, Dividend was 0.09 CAD — a change of 122.22% (higher).

Dividend

0.20CAD

YoY

122.22%

Dividend yield

1.36 %

Last updated:

How much dividend does BioSyent 2026 pay?

According to the latest status from August 2026, BioSyent paid a total of 0.20 CAD per share in dividends within the last 12 months. With the current BioSyent price of 14.75 CAD, this corresponds to a dividend yield of 1.36 %. A dividend is paid times per year.

BioSyent currently offers a dividend yield of about 1.36%. The payout ratio is around 17% of earnings. The dividend has grown at 71.0% per year over the past 3 years.

Historical BioSyent Dividends

A dividend is paid times per year. Last year, the payout months were March, June, September and December.

PaydateDividend
3/27/20260.06CAD
12/28/20250.05CAD
9/29/20250.05CAD
6/30/20250.05CAD
3/28/20250.05CAD
12/29/20240.05CAD
10/4/20240.05CAD
7/1/20240.05CAD
3/28/20240.05CAD
12/29/20230.04CAD
9/30/20230.04CAD
7/1/20230.04CAD
3/27/20230.04CAD
12/29/20220.04CAD

BioSyent dividend history and estimates

In 2025, BioSyent paid a dividend amounting to 0.20 CAD. Dividend means that BioSyent distributes a portion of its profits to its owners.

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2022 (e)
0.04 CAD
0.12 CAD
Jan 1, 2023
0.16 CAD
0.00 CAD
Jan 1, 2024
0.18 CAD
0.00 CAD
Jan 1, 2025
0.20 CAD
0.00 CAD
Jan 1, 2026 (e)
0.06 CAD
0.17 CAD
Jan 1, 2027 (e)
0.00 CAD
0.25 CAD
Jan 1, 2028 (e)
0.00 CAD
0.28 CAD

Is the BioSyent Dividend Safe?

BioSyent has been increasing the dividend for 3 years.

Analysts expect a Dividend Increase of 4.88% for the current fiscal year.

BioSyent dividend payout ratio

In 2025, BioSyent had a payout ratio of 17.43%. The payout ratio indicates the percentage of the company's profits that BioSyent distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
17.43 %
Jan 1, 2022
8.87 %
Jan 1, 2023
29.08 %
Jan 1, 2024
14.34 %
Jan 1, 2025
17.43 %
Jan 1, 2026 (e)
24.72 %
Jan 1, 2027 (e)
22.77 %
Jan 1, 2028 (e)
21.83 %

Dividend Details

Understanding BioSyent's Dividend Distributions

BioSyent’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining BioSyent's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

BioSyent's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in BioSyent’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

BioSyent Stock analysis

What does BioSyent do? Biosyent Inc is a Canadian pharmaceutical company founded in 2004. The company's headquarters are located in Mississauga, Ontario. Biosyent is listed on the Toronto Stock Exchange and has a market capitalization of approximately 140 million Canadian dollars. The company's business model is based on acquiring domestic pharmaceutical and nutraceutical products and marketing them in Canada. Biosyent operates in two main divisions: Pharma and Nutraceuticals. The Pharma division includes products such as RepaGyn, a vaginal gel for treating dryness and irritation during menopause, as well as the antiemetic Setofilm/Tablets for the prevention and treatment of nausea and vomiting. The Nutraceutical division includes products such as FeraMAX, a supplement that increases iron in the diet and helps prevent the development of anemia. Biosyent also offers vitamin-rich dietary supplements such as Aerobic Oxygen and Calm Biotic, targeting health-conscious customers. Another important area of Biosyent is Hospital Specialty Pharmaceuticals, targeting hospitals and healthcare facilities. This includes products like Cysview and Cysview Kit, used to detect non-muscle invasive bladder cancer and improve fluorescence during cystoscopy. Biosyent also offers infusion sets designed for intravenous medication administration. Overall, Biosyent has more than 20 products in various categories including women's and men's health, ophthalmology, immunology, and oncology. Over the years, Biosyent Inc has received various awards for its products and business practices. In 2012, the company received the Bio-Wellness Award for its flagship product, RepaGyn. While Biosyent has ambitions to expand its presence in international markets, the company remains primarily focused on the Canadian market. Biosyent relies mainly on a low-cost marketing strategy that aims to directly target patients in order to market its products in a simple way. Overall, Biosyent has a strong market position in Canada and a portfolio of well-established products. The company has a successful history and appears ready for the future with a strong pipeline and a growing presence in the Canadian market. BioSyent is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BioSyent stock

Over the past 12 months, BioSyent paid a dividend of 0.20 CAD . This corresponds to a dividend yield of about 1.36 %. For the coming 12 months, BioSyent is expected to pay a dividend of 0.25 CAD.

The current dividend yield of BioSyent is 1.36 %.

BioSyent pays a dividend, distributed in the months of , , , .

BioSyent paid dividends every year for the past 4 years.

For the upcoming 12 months, dividends amounting to 0.25 CAD are expected. This corresponds to a dividend yield of 1.67 %.

BioSyent is assigned to the 'Health' sector.

To receive the latest dividend of BioSyent from amounting to 0.06 CAD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, BioSyent distributed 0.18 CAD as dividends.

The dividends of BioSyent are distributed in CAD.

Dividend calendar 2026
Access this data via the Eulerpool API
Get Free API Key

All Key Metrics — BioSyent